date,title,source
Oct-22-18,Alpine Immune Sciences Lead Program ALPN-101 Demonstrates Preclinical Activity in Inflammatory Arthritis and Neurological Inflammation,Business Wire
Nov-01-18,Alpine Immune Sciences Announces Scientific Presentations at 60th American Society of Hematology Annual Meeting and Exposition,Business Wire
Nov-05-18,Analysts Estimate Alpine Immune Sciences (ALPN) to Report a Decline in Earnings: What to Look Out for,Zacks
Nov-05-18,Alpine Immune Sciences to Present at Two Upcoming Investor Conferences,Business Wire
Nov-08-18,Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2018 Financial Results,Business Wire
Nov-09-18,Alpine Immune Sciences Advances Oncology Programs with New ALPN-202 Preclinical Data and Key Additions to Scientific Advisory Board,Business Wire
Nov-29-18,Alpine Immune Sciences Announces ALPN-101 Data to be Included in Oral Presentation at 60th American Society of Hematology Annual Meeting and Exposition,Business Wire
